Our results showed that plasma Nt-proBNP levels were lower in CHF patients with metabolic syndrome attributable to inverse relationships between plasma Nt-proBNP and body mass index (BMI), plasma triglyceride and homeostasis model assessment of insulin resistance (HOMA-IR). The gene discussed is NPPB; the disease is Insulin resistance.